What is Jumpcode Genomics?
Jumpcode Genomics is at the forefront of enhancing the utility of next-generation sequencing (NGS) data. The company develops innovative solutions, including programmable endonuclease enzymes and specialized depletion kits, designed to refine single-cell analysis, microbiome characterization, infectious disease detection, and whole transcriptome profiling. Their offerings are tailored for academic institutions and researchers dedicated to genomics and molecular biology, aiming to convert uninformative sequenced molecules into valuable, interpretable data. This focus positions Jumpcode Genomics as a key player in the rapidly evolving field of genomic data science.
How much funding has Jumpcode Genomics raised?
Jumpcode Genomics has raised a total of $24.5M across 2 funding rounds:
Series A
$3.5M
Series B
$21M
Series A (2018): $3.5M, investors not publicly disclosed
Series B (2021): $21M led by Baird Capital, LYZZ Capital Advisors, and Arboretum Ventures LLC
Key Investors in Jumpcode Genomics
Baird Capital
Baird Capital is a global venture capital firm specializing in founder-led B2B tech and services companies. They focus on sectors where they possess deep knowledge, offering operational support and expertise to foster growth and scale.
LYZZ Capital Advisors
LYZZ Capital Advisors is an entity involved in the recent funding round for Jumpcode Genomics, contributing to the company's strategic growth initiatives.
Arboretum Ventures LLC
Arboretum Ventures LLC is a participant in Jumpcode Genomics' latest financing, indicating a strategic interest in the company's advancements in genomic data solutions.
What's next for Jumpcode Genomics?
With the recent infusion of capital, Jumpcode Genomics is poised for significant expansion and technological advancement. The strategic investment will likely fuel further research and development into their proprietary enzyme and depletion kit technologies, potentially broadening their application in complex biological studies. This funding will also enable Jumpcode Genomics to scale its operations, enhance its market reach, and solidify its position as a leader in providing researchers with the tools needed to unlock the full potential of NGS data. The company's trajectory suggests a continued commitment to innovation and a growing influence in the genomics sector.
See full Jumpcode Genomics company page
